ACS Chem. Biol., 2009, 4 (1), pp 65–74 Artem Cherkasov, Kai Hilpert, Håvard Jenssen, Christopher D. Fjell, Matt Waldbrook, Sarah C. Mullaly, Rudolf Volkmer.

Slides:



Advertisements
Similar presentations
Analysis of High-Throughput Screening Data C371 Fall 2004.
Advertisements

12.1 Identifying the Substance of Genes
12.1 Identifying the Substance of Genes
BETHLEHEM UNIVERSITY Second Neonatal Gathering Fall 2007.
1 Molecular genetics of bacteria Emphasis: ways that bacteria differ from eukaryotes DNA structure and function; definitions. DNA replication Transcription.
Training a Neural Network to Recognize Phage Major Capsid Proteins Author: Michael Arnoult, San Diego State University Mentors: Victor Seguritan, Anca.
Biology 107 Carbon and Molecular Diversity September 4, 2002.
30. Genetics and recombination in bacteria. Lecture Outline 11/16/05 Replication in bacteria Types of recombination in bacteria –Transduction by phage.
Biol518 Lecture 2 HTS and Antibiotic Drug Discovery.
Mathematical Modelling of Phage Dynamics: Applications in STEC studies Tom Evans.
1 Antimicrobial Therapy Chemotherapy: any treatment of patient with chemicals to treat a condition. –Now word associated with cancer treatment –Our focus.
THE BUILDING BLOCKS OF LIFE. BUILT FOR YOU Putting Engineering back into Protein Engineering Jun Liao, UC Santa Cruz Manfred K. Warmuth, UC Santa Cruz.
Training a Neural Network to Recognize Phage Major Capsid Proteins Author: Michael Arnoult, San Diego State University Mentors: Victor Seguritan, Anca.
Antibiotics and genetic variation in bacteria. Objectives Antibiotics Antibiotics don’t work against viruses. Antibiotics may be used to treat bacterial.
1 Antimicrobial Therapy Chemotherapy: any treatment of patient with chemicals to treat a condition. –Now word associated with cancer treatment –Our focus.
Biology 107 Carbon and Molecular Diversity September 3, 2003.
What do all of these have in common?. Natural Products Drug Discovery Searching for Cures in the Plant Kingdom They all contain natural products…
CHEMICAL COMPOUNDS OF LIFE
Today we are covering from the specification:. Starter 1.What are antibiotics used for? 2.Who can obtain antibiotics? 3.When shouldn’t antibiotics be.
Antibiotics Bio February 2010 Ethan Richman Ben Kwak Ampicillin, Tetracyclin, and Chloramphenicol.
Drug Action and Drug Design. Stereoisomers Stereoisomers are isomers with the same molecular formula AND the same structural formula, but a different.
Molecular Biology & Biotechnology
12.1 Identifying the Substance of Genes
Because bacteria are so small, we use measurements called MICRONS to measure them. 1 mm = 1000microns Bacteria are much smaller than animal cells. The.
SUPERVISED NEURAL NETWORKS FOR PROTEIN SEQUENCE ANALYSIS Lecture 11 Dr Lee Nung Kion Faculty of Cognitive Sciences and Human Development UNIMAS,
Biol518 Lecture 2 HTS and Antibiotic Drug Discovery.
Chemical bases of life. Matter, Mass, and Weight All living and nonliving things are composed of matter, which is anything that occupies space and has.
Immune System & Disease
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 83 Basic Principles of Antimicrobial Therapy.
Chapter 13. The Impact of Genomics on Antimicrobial Drug Discovery and Toxicology CBBL - Young-sik Sohn-
Battling bacterial evolution: The work of Carl Bergstrom
Introduction to Chemoinformatics Irene Kouskoumvekaki Associate Professor December 12th, 2012 Biological Sequence Analysis course.
Technological Solutions. In 1977 Sanger et al. were able to work out the complete nucleotide sequence in a virus – (Phage 0X174) This breakthrough allowed.
CS 790 – Bioinformatics Introduction and overview.
D9 Drug design Compound libraries Combinatorial and parallel chemistry
Microbial Biotechnology Philadelphia University
Use of Machine Learning in Chemoinformatics Irene Kouskoumvekaki Associate Professor December 12th, 2012 Biological Sequence Analysis course.
N.S. Lecture 3 – Biochemistry is broken up into 3 parts - this is part 3b.
“Emergency discovery” of novel antimicrobials among known drugs in response to new and re-emerging infectious threats A. Cherkasov UBC / VGH Infectious.
Polymer Molecule made of many monomers bonded together
A design for cellular evolutionary computation by using bacteria
CLINICAL PHARMACOLOGY OF ANTIBACTERIAL AGENTS. Actions of antibacterial drugs on bacterial cells.
Matter – anything that takes up space and has weight; composed of elements Elements – composed of chemically identical atoms as of 2002, 114 elements known,
Antibiotic Resistance
Human Genomics. Writing in RED indicates the SQA outcomes. Writing in BLACK explains these outcomes in depth.
Bacteria and antibiotics Page refs for this section = Textbook p
Chapter 20-Antimicrobial Agents _______________:The use of drugs to treat a disease (not necessarily infectious) Antimicrobial drugs: Interfere with the.
IMMUNE SYSTEM & DISEASE A Brief Introduction. What Is Your Immune System?  AAAACHHOOO!! Your friend has a terrible cold, and he sneezes right next to.
Antimicrobial drugs. Antimicrobial drugs are effective in the treatment of infections because of their selective toxicity (that is, they have the ability.
Introduction to Chemoinformatics and Drug Discovery Irene Kouskoumvekaki Associate Professor February 15 th, 2013.
NOTES - CH 15 (and 14.3): DNA Technology (“Biotech”)
+ Antibiotic Resistance. Discovering Antibiotics Alexander Fleming Left his culture of bacteria exposed overnight. Found that mold growing on the.
Plants and Fungi Used to Treat Infectious Disease
Use of Machine Learning in Chemoinformatics
Chemotherapeutic Agents   Chemotherapy is a general term referring to the use of a drug to kill or weaken invading cells or organisms without harming.
Inhibiting Microbial Growth in vivo CLS 212: Medical Microbiology.
Artificial Neural Networks (ANN). Artificial Neural Networks First proposed in 1940s as an attempt to simulate the human brain’s cognitive learning processes.
Medicines and drugs antibacterials. Diseases caused by bacteria  tuberculosis,  syphilis,  cholera,  salmonella,  bronchitis,  anthrax,  meningitis,
Evolution of Bacteria Joshua Jackson 2 nd Period Biology Honors.
Lesson Overview Lesson Overview Diseases Caused by Bacteria and Viruses Lesson Overview 20.3 Diseases Caused by Bacteria and Viruses.
Immune System Day 1.
 Antimicrobial agents share certain common properties.  We can learn much about how these agents work and why they sometimes do not work by considering.
Antibiotics (anti-microbials)
+ Immune System. + What are the basics?  _____________________  _____________________is the ability of an organism to maintain a stable internal environment.
Proteins. Chemical composition of the proteins
Treatment of Infectious Disease
APPLICATIONS OF BIOINFORMATICS IN DRUG DISCOVERY
Volume 16, Issue 1, Pages (January 2009)
Molecular genetics of bacteria
Presentation transcript:

ACS Chem. Biol., 2009, 4 (1), pp 65–74 Artem Cherkasov, Kai Hilpert, Håvard Jenssen, Christopher D. Fjell, Matt Waldbrook, Sarah C. Mullaly, Rudolf Volkmer § and Robert E.W. Hancock

Consider the following harrowing facts:  In 2002, 57.1 percent (an estimated 102,000 cases) of the staph bacteria found in U.S. hospitals were methicillin-resistant (MRSA), according to CDC.  The total cost of antimicrobial resistance to U.S. society is nearly $5 billion annually, according to the Institute of Medicine (IOM).  About 2 million people acquire bacterial infections in U.S. hospitals each year, and 90,000 die as a result. About 70 percent of those infections are resistant to at least one drug, according to the Centers for Disease Control and Prevention.  Recent CDC data show that in 2002, nearly 33 percent of tested samples from ICUs were resistant to fluoroquinolones. P. aeruginosa causes infections of the urinary tract, lungs, and wounds and other infections commonly found in intensive care units. MRSA MRSA infected human tissue

Antibiotic: a substance that kills or inhibits the growth of bacteria (e.g. penicillin, erythromycin, anisomycin,etc) Erythromycin Penicillin Anisomycin

Different types of bacteria exhibit different ways of resistance. Some contain enzymes to change the chemical structure of the antibiotic. Some contain enzymes capable of splitting the antibiotic molecule apart. Some are able to “flush” the antibiotic out of the cell before it can fatally wreck the little creature. Each of these abilities are encoded by resistance genes often found in bacterial plasmid.

 Peptide: a polymer made up of amino acid monomers (e.g. the 9-mer KRWWKWIRW in Hancock et al)  Peptides antibiotics are simply antibiotics that are composed either partially or wholly of amino acids.  Almost all species have evolved antimicrobial peptides capable of attacking microbes directly, or, indirectly, by bringing about an innate or inflammatory immune response. Actinomycin D Various peptide antibiotic ribbon structures

 Scientific goal: Based on a antimicrobial peptide found in nature, in this case the bovine (as in cow) neutrophil cationic peptide bactenecin (RLCRIVVIRVCR-NH-2), that is known to serve a desirable function per this study, perhaps we can scramble its AA sequence to determine if there are even better antimicrobial peptides of the same length. Cattle neutrophil bactenecin RLCRIVVIRVCR-NH 2 (from left to right)

Each circular region contains a synthesized peptide. The tiny penciled-in dots are the actual specific peptides. Each of these can be punched out and tested for various biological functions (e.g. antimicrobial activity).

 Lux assay (no graphical representation depicted in reference 20) is accomplished by taking the peptides from the SPOT synthesis, punching them out, transferring them to microtiter plates, and seeing if they reduce the ability of P. aeruginosa to bioluminescence.  An active antimicrobial peptide will destroy the P. aeruginosa and stop its from luminescence.  An inactive antimicrobial peptide will not destroy P. aeruginosa and thus the organism’s beautiful bioluminescent display will persist.  Combinations of single or multiple AA substitutions led to peptides with better antimicrobial activity than Bac2A.

 Preferred AAs are found in the best antimicrobial peptides from (refs. 20, 21). They tend to be hydrophobic and amphiphathic AAs.  Using these preferred AAs from (refs. 20, 21) the authors design sets of 943 and 500 cellulose peptides (sets A and B respectively).  Best set A amino acid preferences were used to adjust the amino acid composition of set B.  Adjustments made to set B resulted in better antimicrobial activity than set A relative to Bac2A.  Amino acid composition of set B thus formed to the lead amino acids to be tested in silico. Figure 1. Occurrence of amino acids in the training and QSAR predicted data sets. The predicted activity quartiles from the 100,000 virtual peptide library are marked as Q1−Q4.

 Set B peptide AA preferences, representing the best amino acid sequences (increased Ile, Arg, Val, and Trp) were used for random computer generation of 100, 000 virtual peptides (out of an astounding 70 billion possible 9-mer variants.  No position-specific requirements and 16 out of 20 natural AAs used in simulation.  4 peptides were not used (3 residues were found not make for good antimicrobials in previous libraries and cysteine results in dimerization via disulphide formation.  QSAR solutions from sets A and B were used to help evaluate the effectiveness of these 100, 000 virtual peptides.  QSAR?

 Quantative Structure-Activity Relationships  A QSAR is a mathematical association between a biological goings-on of a molecular system and its geometric and chemical characteristics.  QSAR attempts to find reliable relationship between biological activity and molecular properties, so that these “rules” can be used to assess the activity of new compounds.  Sets A and B were used to create QSAR models relating chemical characteristics to antimicrobial activity.  Artificial neural network was used to relate chemical descriptors to antimicrobial activity for the 100, 000 computer generated peptides.  100, 000 peptides were broken down into four quartiles based on activity predicted : high, medium, low, and completely inactive.

 “Chemical space” is the short qualitative answer to the following question: “How many different types of chemical compounds are theoretically capable of existing?”  Chemical space includes: biopolymers, synthetic polymers, metallic clusters, small carbon-based compounds, organometallic systems, etc.  Not all of chemical space may be biologically relevant. Even so, the number of small carbon based molecules with a molecular weight of less than 500 daltons (the molecular mass of many compounds found in living systems) is estimated to be 1 x 10^60!  The number of compounds required for synthesis in order to place 10 different groups in 4 positions of benzene ring is 10 4  In silico modeling is thus necessary to search through small parts of chemical space in a reasonable time and cost-effective manner.  A type of chemoinformatic computer modeling called QSAR is one of the methods by which a virtual library of compounds can be generated from lead compounds with certain desirable “drug-like” characteristics.  But first, for the purposes of this study, a lead antimicrobial peptide must be developed and its biological activity determined (set B in Hancock et al 2009).

 neural networks are attempt to make computers process information like human neurons.  The human brain is essentially a vast array of interconnected neurons that respond differently to different types of information  Massive interconnectivity allows for many parameters to be looked all at once as opposed to regression analysis which typically deals with a much smaller number of variables.  Authors refer to ANN using a “black box” metaphor—that is, they are not totally sure how the neural network is coming up with its results. The authors leave to a future paper an attempt to explain how the ANN is working its magic (Hancock et al, 2009 in prep.) Artificial Neural Network

Figure 2. Antimicrobial activity and physical parameters for antimicrobial peptides from Training Sets A and B and peptides from the 100,000 peptide virtual library.

Figure 3: Ability of the Peptides HHC-10 and HHC-36 to protect mice against invasive S. Aureus infection Tests of Candidate Peptide Antibiotic Effectiveness

Starting peptide AA Sequence scrambled versions SPOT syn/lux assay Superior training compounds In silico QSAR/ANN analysis

 Not just theory: peptide antibiotic MX-226 has been shown to significantly limit catheter colonization in phase IIIa clinical trials.  QSAR/ANN is not a one cycle process. It exhibits positive feedback: lead compound to improved virtual compound to drug candidate which may then be used in turn as a lead compound, ad infinitum.  Peptide antibiotics have some negative characteristics such as unknown toxicities, degradation by proteases (enzymes that break down proteins), and high cost (amino acids are expensive building blocks).  Not all of the structural characteristics of what makes a good peptide antibiotic are known at this time.

 Dr. Case  The students of Chem258  Antibiotics and bacteria